Santhera Pharmaceuticals Holding AG

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 170
EBIT TTM (mln): 110
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Przychód (mln) 2 21 3 4 1 3 4 19 23 32 75 15 -2 7
Przychód Δ r/r 0.0% 1154.4% -84.2% 8.4% -62.7% 96.4% 66.8% 340.5% 20.5% 38.0% 138.1% -80.1% -110.6% -568.5%
Marża brutto 85.1% 98.2% 89.6% 90.1% 89.4% 92.3% 68.3% 79.6% 82.1% 85.1% 92.8% 30.5% 336.2% 51.9%
EBIT (mln) -47 -9 -27 -31 -7 -8 3 -33 -50 -51 -10 -53 -57 -52
EBIT Δ r/r 0.0% -81.3% 212.4% 14.5% -76.5% 2.8% -142.2% -1144.0% 52.3% 1.9% -79.7% 408.3% 7.2% -8.6%
EBIT (%) -2835.7% -42.3% -833.5% -880.6% -554.1% -290.1% 73.4% -174.1% -219.9% -162.4% -13.9% -353.7% 3566.6% -695.5%
Koszty finansowe (mln) 4 7 4 0 0 0 0 0 4 5 6 7 16 20
EBITDA (mln) 31 -2 -23 -11 -5 -7 -23 -30 -47 -48 -7 -54 -43 -42
EBITDA(%) 1872.0% -9.9% -694.9% -313.6% -389.8% -287.5% -533.1% -157.2% -203.1% -152.3% -9.5% -359.3% 2710.1% -568.6%
Podatek (mln) -0 -0 0 0 -0 0 -3 2 0 0 1 0 1 0
Zysk Netto (mln) 26 -11 -28 -31 -6 -8 6 -35 -52 -54 -19 -68 -56 -71
Zysk netto Δ r/r 0.0% -143.4% 147.3% 13.0% -81.7% 30.9% -179.0% -695.3% 45.5% 5.2% -65.0% 256.6% -17.9% 28.0%
Zysk netto (%) 1577.8% -54.6% -852.6% -888.9% -436.3% -290.8% 137.7% -186.1% -224.6% -171.2% -25.2% -450.8% 3481.3% -951.1%
EPS -73.1 -30.76 -75.95 -85.53 -15.52 -16.02 11.1 -56.45 -82.19 -78.63 -17.26 -50.81 -16.25 -11.67
EPS (rozwodnione) -73.1 -30.76 -75.95 -85.53 -15.52 -16.02 10.8 -56.45 -82.19 -78.63 -17.26 -50.81 -16.25 -11.67
Ilośc akcji (mln) 0 0 0 0 0 0 1 1 1 1 1 1 3 6
Ważona ilośc akcji (mln) 0 0 0 0 0 0 1 1 1 1 1 1 3 6
Waluta CHF CHF CHF CHF CHF CHF CHF CHF CHF CHF CHF CHF CHF CHF